After Myriad, What Types of Claim Amendments Change a Patent Ineligible Isolated Gene Claim Into an Eligible Patent Claim That Is ‘Markedly Different’ From Nature?
35 Nature Biotechnology 820-825
31 Pages Posted: 22 May 2018
Date Written: September 11, 2017
Using a novel research method, this paper examines the types of claim amendments that have transformed isolated gene claims from patent-ineligible into eligible subject matter. It also provides clarity into the threshold of eligibility for gene-related patents.
Keywords: Patents, Patent Law, Biotechnology, Myriad, Gene Patents, US, Empirical Legal Research
Suggested Citation: Suggested Citation